These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 24598721)
1. Rabies virus glycoprotein and immune response pattern using recombinant protein or recombinant RNA viral vectors. Astray RM; Ventini DC; Boldorini VL; Silva FG; Rocca MP; Pereira CA Vaccine; 2014 May; 32(24):2829-32. PubMed ID: 24598721 [TBL] [Abstract][Full Text] [Related]
2. A sindbis virus replicon-based DNA vaccine encoding the rabies virus glycoprotein elicits immune responses and complete protection in mice from lethal challenge. Saxena S; Dahiya SS; Sonwane AA; Patel CL; Saini M; Rai A; Gupta PK Vaccine; 2008 Dec; 26(51):6592-601. PubMed ID: 18848857 [TBL] [Abstract][Full Text] [Related]
3. Rabies vaccine development by expression of recombinant viral glycoprotein. Astray RM; Jorge SA; Pereira CA Arch Virol; 2017 Feb; 162(2):323-332. PubMed ID: 27796547 [TBL] [Abstract][Full Text] [Related]
4. Generation and evaluation of a recombinant modified vaccinia virus Ankara vaccine for rabies. Weyer J; Rupprecht CE; Mans J; Viljoen GJ; Nel LH Vaccine; 2007 May; 25(21):4213-22. PubMed ID: 17434244 [TBL] [Abstract][Full Text] [Related]
5. A DNA vaccine that encodes rabies virus glycoprotein lacking transmembrane domain enhances antibody response but not protection. Gupta PK; Sharma S; Walunj SS; Patil AA; Rai A; Saini M Acta Virol; 2006; 50(2):87-92. PubMed ID: 16808325 [TBL] [Abstract][Full Text] [Related]
6. Chimeric rabies virus-like particles containing membrane-anchored GM-CSF enhances the immune response against rabies virus. Kang H; Qi Y; Wang H; Zheng X; Gao Y; Li N; Yang S; Xia X Viruses; 2015 Mar; 7(3):1134-52. PubMed ID: 25768031 [TBL] [Abstract][Full Text] [Related]
7. Induction of immune responses and protection in mice against rabies using a self-replicating RNA vaccine encoding rabies virus glycoprotein. Saxena S; Sonwane AA; Dahiya SS; Patel CL; Saini M; Rai A; Gupta PK Vet Microbiol; 2009 Apr; 136(1-2):36-44. PubMed ID: 19081687 [TBL] [Abstract][Full Text] [Related]
8. Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene. Cenna J; Tan GS; Papaneri AB; Dietzschold B; Schnell MJ; McGettigan JP Vaccine; 2008 Nov; 26(50):6405-14. PubMed ID: 18804506 [TBL] [Abstract][Full Text] [Related]
9. A comparative approach between heterologous prime-boost vaccination strategy and DNA vaccinations for rabies. Borhani K; Ajorloo M; Bamdad T; Mozhgani SH; Ghaderi M; Gholami AR Arch Iran Med; 2015 Apr; 18(4):223-7. PubMed ID: 25841942 [TBL] [Abstract][Full Text] [Related]
10. A nucleoside-modified mRNA vaccine forming rabies virus-like particle elicits strong cellular and humoral immune responses against rabies virus infection in mice. Liu J; Sun J; Ding X; Liu W; Wang Y; Wang Z; Peng H; Zhang Y; Su W; Jiang C Emerg Microbes Infect; 2024 Dec; 13(1):2389115. PubMed ID: 39129566 [TBL] [Abstract][Full Text] [Related]
11. Glycoprotein from street rabies virus BD06 induces early and robust immune responses when expressed from a non-replicative adenovirus recombinant. Wang S; Sun C; Zhang S; Zhang X; Liu Y; Wang Y; Zhang F; Wu X; Hu R Arch Virol; 2015 Sep; 160(9):2315-23. PubMed ID: 26143474 [TBL] [Abstract][Full Text] [Related]
12. Construction and immunogenicity of a recombinant pseudotype baculovirus expressing the glycoprotein of rabies virus in mice. Huang H; Xiao S; Qin J; Jiang Y; Yang S; Li T; Gao Y; Li Z; Li T; Su X; Ruan Y; Xu F; Wang H; Chen H; Xia X Arch Virol; 2011 May; 156(5):753-8. PubMed ID: 21221673 [TBL] [Abstract][Full Text] [Related]
13. Rabies virus-like particles expressed in HEK293 cells. Fontana D; Kratje R; Etcheverrigaray M; Prieto C Vaccine; 2014 May; 32(24):2799-804. PubMed ID: 24631077 [TBL] [Abstract][Full Text] [Related]
14. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Xiang ZQ; Spitalnik S; Tran M; Wunner WH; Cheng J; Ertl HC Virology; 1994 Feb; 199(1):132-40. PubMed ID: 8116236 [TBL] [Abstract][Full Text] [Related]
15. A recombinant rabies vaccine expressing the trimeric form of the glycoprotein confers enhanced immunogenicity and protection in outbred mice. Koraka P; Bosch BJ; Cox M; Chubet R; Amerongen Gv; Lövgren-Bengtsson K; Martina BE; Roose J; Rottier PJ; Osterhaus AD Vaccine; 2014 Aug; 32(36):4644-50. PubMed ID: 24962755 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the immunogenicity of two inactivated recombinant rabies viruses overexpressing the glycoprotein. Navid MT; Li Y; Zhou M; Cui M; Fu ZF; Tang L; Zhao L Arch Virol; 2016 Oct; 161(10):2863-70. PubMed ID: 27438075 [TBL] [Abstract][Full Text] [Related]
17. Rabies DNA vaccine encoding lysosome-targeted glycoprotein supplemented with Emulsigen-D confers complete protection in preexposure and postexposure studies in BALB/c mice. Kaur M; Saxena A; Rai A; Bhatnagar R FASEB J; 2010 Jan; 24(1):173-83. PubMed ID: 19741168 [TBL] [Abstract][Full Text] [Related]
18. [Immune response of mice to replication-defective recombinant adenovirus containing glycoprotein gene of rabies virus 3aG strain]. Li W; Zhang Y; Wang S Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Mar; 15(1):61-5. PubMed ID: 12526306 [TBL] [Abstract][Full Text] [Related]
19. A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice. Li J; Faber M; Papaneri A; Faber ML; McGettigan JP; Schnell MJ; Dietzschold B Virology; 2006 Dec 5-20; 356(1-2):147-54. PubMed ID: 16938327 [TBL] [Abstract][Full Text] [Related]
20. Recombinant canine distemper virus serves as bivalent live vaccine against rabies and canine distemper. Wang X; Feng N; Ge J; Shuai L; Peng L; Gao Y; Yang S; Xia X; Bu Z Vaccine; 2012 Jul; 30(34):5067-72. PubMed ID: 22698451 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]